News Repligen Corporation

Equities

RGEN

US7599161095

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
141.2 ^USD	-3.12%		-6.07%	-21.45%

Jun. 06	Transcript : Repligen Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 11:30 AM
Jun. 05	Transcript : Repligen Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 12:00 PM

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Repligen Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 11:30 AM	Jun. 06
Transcript : Repligen Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 12:00 PM	Jun. 05
Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing	Jun. 03	CI
Transcript : Repligen Corporation Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 08:40 AM	May. 30
Repligen Insider Sold Shares Worth $3,377,283, According to a Recent SEC Filing	May. 22	MT
Repligen Corporation to Present at Upcoming June Investor Conferences	May. 22	AQ
Repligen : Investor Presentation May 2024 Presentation	May. 16	PU
Transcript : Repligen Corporation Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 10:30 AM	May. 14
Repligen Corporation to Present at Upcoming May Investor Conferences	May. 07	AQ
UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating	May. 02	MT
Repligen's Q1 Adjusted Earnings, Revenue Fall	May. 01	MT
Transcript : Repligen Corporation, Q1 2024 Earnings Call, May 01, 2024	May. 01
(RGEN) REPLIGEN CORPORATION Sees Fiscal Year 2024 EPS Range $1.42 - $1.49	May. 01	MT
Repligen: Q1 Earnings Snapshot	May. 01	AQ
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $151.3M, vs. Street Est of $150.1M	May. 01	MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Adjusted Q1 EPS $0.28, vs. Street Est of $0.30	May. 01	MT
Repligen Reports First Quarter 2024 Financial Results	May. 01	AQ
Repligen Corporation Provides Earnings Guidance for the Fiscal Year 2024	May. 01	CI
Repligen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
North American Morning Briefing : Traders Wait for -2-	May. 01	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Repligen Corporation

Equities

RGEN

US7599161095

Summary

Filters